ondansetron has been researched along with Enterocolitis in 12 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Enterocolitis: Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.
| Excerpt | Relevance | Reference |
|---|---|---|
| ": J Allergy Clin Immunol 2013;132:1219-1220] documented the efficacy of the intravenous administration of ondansetron in children with acute symptoms due to food protein-induced enterocolitis syndrome (FPIES)." | 7.80 | Ondansetron for food protein-induced enterocolitis syndrome. ( Battista, A; Greco, M; Miceli Sopo, S; Monaco, S, 2014) |
| "Ondansetron has been suggested as an adjunctive treatment." | 5.46 | Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study. ( Bersani, G; Campbell, D; Cerchiara, G; Lee, E; Mehr, S; Miceli Sopo, S; Monaco, S, 2017) |
| ": J Allergy Clin Immunol 2013;132:1219-1220] documented the efficacy of the intravenous administration of ondansetron in children with acute symptoms due to food protein-induced enterocolitis syndrome (FPIES)." | 3.80 | Ondansetron for food protein-induced enterocolitis syndrome. ( Battista, A; Greco, M; Miceli Sopo, S; Monaco, S, 2014) |
| "Ondansetron has been suggested as an adjunctive treatment." | 1.46 | Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study. ( Bersani, G; Campbell, D; Cerchiara, G; Lee, E; Mehr, S; Miceli Sopo, S; Monaco, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, M | 1 |
| Caubet, JC | 2 |
| Cianferoni, A | 1 |
| Groetch, M | 1 |
| Nowak-Wegrzyn, A | 3 |
| Le, S | 1 |
| de Boissieu, D | 1 |
| Garcelon, N | 1 |
| Lageix, F | 1 |
| Bodilis, H | 1 |
| Branellec, A | 1 |
| Karila, C | 1 |
| Faour, H | 1 |
| Delacourt, C | 1 |
| Lezmi, G | 1 |
| Leonard, SA | 1 |
| Miceli Sopo, S | 3 |
| Baker, MG | 1 |
| Fiocchi, A | 1 |
| Wood, RA | 2 |
| Ruffner, MA | 1 |
| Spergel, JM | 1 |
| Brown-Whitehorn, TF | 1 |
| Ford, LS | 1 |
| Konstantinou, GN | 1 |
| You, L | 1 |
| Shafi, S | 1 |
| Soffer, G | 1 |
| Agyemang, A | 1 |
| Holbrook, T | 1 |
| Keet, CA | 1 |
| Frischmeyer-Guerrerio, PA | 1 |
| Battista, A | 1 |
| Greco, M | 1 |
| Monaco, S | 2 |
| Ta, V | 1 |
| Tsang, RS | 1 |
| Mannino Avila, E | 1 |
| Ann Leonard, S | 1 |
| Bersani, G | 1 |
| Cerchiara, G | 1 |
| Lee, E | 1 |
| Campbell, D | 1 |
| Mehr, S | 1 |
4 reviews available for ondansetron and Enterocolitis
| Article | Year |
|---|---|
Food protein-induced enterocolitis syndrome.
Topics: Adult; Biomarkers; Dietary Proteins; Enterocolitis; Female; Food Hypersensitivity; Humans; Infant; I | 2019 |
Management of acute food protein-induced enterocolitis syndrome emergencies at home and in a medical facility.
Topics: Adrenal Cortex Hormones; Allergens; Antiemetics; Dietary Proteins; Enterocolitis; Food Hypersensitiv | 2021 |
PRO: Peripheral intravenous access should always be secured before initiating food protein-induced enterocolitis syndrome oral food challenge.
Topics: Allergens; Antiemetics; Dietary Proteins; Enterocolitis; Food Hypersensitivity; Humans; Ondansetron | 2021 |
Food Protein-Induced Enterocolitis Syndrome: a Comprehensive Review.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Allergens; Antiemetics; Child; Child, Preschool; Diagnos | 2019 |
8 other studies available for ondansetron and Enterocolitis
| Article | Year |
|---|---|
Food Protein-induced Enterocolitis Syndrome.
Topics: Allergens; Dietary Proteins; Enterocolitis; Food Hypersensitivity; Humans; Ondansetron; Vomiting | 2023 |
Efficacy of oral ondansetron in acute FPIES: A case series of 6 patients.
Topics: Enterocolitis; Food Hypersensitivity; Humans; Infant; Ondansetron | 2020 |
CON: Peripheral intravenous access should always be secured before initiating food protein-induced enterocolitis syndrome oral food challenge.
Topics: Allergens; Antiemetics; Catheterization, Peripheral; Dietary Proteins; Enterocolitis; Food Hypersens | 2021 |
Concomitant cow's milk and beef food protein-induced enterocolitis syndrome in a young infant.
Topics: Animals; Cattle; Enterocolitis; Gastrointestinal Diseases; Humans; Immunoglobulin E; Infant; Infant | 2021 |
Use of ondansetron for food protein-induced enterocolitis syndrome.
Topics: Child; Child, Preschool; Enterocolitis; Female; Food Hypersensitivity; Humans; Male; Ondansetron; Pr | 2013 |
Ondansetron for food protein-induced enterocolitis syndrome.
Topics: Child, Preschool; Enterocolitis; Female; Food Hypersensitivity; Humans; Infant; Male; Ondansetron | 2014 |
Delay in diagnosis of severe food protein-induced enterocolitis syndrome caused by mango.
Topics: Allergens; Delayed Diagnosis; Enterocolitis; Food Hypersensitivity; Humans; Infant; Male; Mangifera; | 2015 |
Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study.
Topics: Allergens; Anti-Allergic Agents; Case-Control Studies; Child, Preschool; Dietary Proteins; Enterocol | 2017 |